The FDA awarded 510(k) clearance to Flexicath for its pressure injectable M/29 Midterm catheters, the company announced last week.
The Pittsburgh-based catheter insertion systems maker aims to address "blood stream infection control issues" with its devices, according to a press release.
The M/29 Midterm features built-in 360-degress Maximum Barrier technology for preventing airborne and touch-borne contamination during catheter insertion, according to the company.
The line also features ultrasound assisted placement and contrast agent administration, in addition to pressure injection rating up to 5 ml per second.
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.